More leakage.
The New England Journal of Medicine and 13 other research publications may force scientists submitting studies to disclose payments from hedge funds in the wake of insider-trading probes involving a drug-maker and technology companies… Existing rules on payments by drugmakers and device companies don’t cover arrangements with investors…
Until recently, Professor Yves Benhamou was toddling along giving CME lectures, publishing his research, and, allegedly, selling insider information to Human Genome Sciences (he’s been arrested). So we’ve got a third area of disclosure opening up.
Haven’t the journals forgotten about researchers whose articles have been ghostwritten by industry? That’s four.